CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2021		3,951,944
Beginning balance at Dec. 31, 2021	$ 191,581,010	$ 3,952	$ 12,331,731	$ 102,315,623	$ 76,929,704
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reverse acquisition with Clinigence (in shares)		339,741
Reverse acquisition with Clinigence	436,695,013	$ 340	436,499,926		194,747
Deconsolidation of Real Estate Entities	(38,803,892)			(6,466,946)	(32,336,946)
Debt conversion to common stock (in shares)		23,163
Debt conversion to common stock	5,385,372	$ 23	5,385,349
Common stock issued for exercise of warrants (in shares)		14,315
Common stock issued for exercise of warrants	4,119,141	$ 14	4,119,127
Common stock issued for exercise of options (in shares)		2,080
Common stock issued for exercise of options	644,974	$ 2	644,972
Common stock issued for acquisition	0
Rescission of warrant exercise (in shares)		(5,460)
Rescission of warrant exercise	(26,391)	$ (5)	(26,386)
Equity financing agreement Lincoln Park Capital Fund, LLC (in shares)		9,042
Equity financing agreement Lincoln Park Capital Fund, LLC	0	$ 9	(9)
Common stock received in sale of business	0
Stock-based compensation	189,581		189,581
Contributions	4,513,867				4,513,867
Distributions	(51,231,657)			(34,354,156)	(16,877,501)
Net income (loss)	(432,739,618)			(424,780,446)	(7,959,172)
End balance (in shares) at Dec. 31, 2022		4,334,825
Ending balance at Dec. 31, 2022	120,327,400	$ 4,335	459,144,291	(363,285,925)	24,464,699
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Deconsolidation of Real Estate Entities	(4,258,133)				(4,258,133)
Debt conversion to common stock (in shares)		142,384
Debt conversion to common stock	6,217,737	$ 142	6,217,595
Common stock issued for exercise of warrants (in shares)		8,456
Common stock issued for exercise of warrants	$ 0	$ 8	(8)
Common stock issued for exercise of options (in shares)	0
Common stock issued (in shares)		6,667
Common stock issued	$ 1,900,000	$ 7	1,899,993
Common stock issued for Employee Stock Purchase Plan (in shares)		515
Common stock issued for Employee Stock Purchase Plan	14,288	$ 1	14,287
Common stock issued for acquisition (in shares)		16,943
Common stock issued for acquisition	905,234	$ 17	905,217
Rescission of warrant exercise	0
Common stock received in sale of business	0
Stock-based compensation (in shares)		1,409
Stock-based compensation	935,967	$ 1	935,966
Warrants issued with convertible debt	1,403,877		1,403,877
Contributions	298,032				298,032
Distributions	(5,214,581)				(5,214,581)
Net income (loss)	(43,423,715)			(45,786,614)	2,362,899
End balance (in shares) at Dec. 31, 2023		4,511,199
Ending balance at Dec. 31, 2023	79,106,106	$ 4,511	470,521,218	(409,072,539)	17,652,916
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Debt conversion to common stock (in shares)		11,824
Debt conversion to common stock	$ 320,688	$ 12	320,676
Common stock issued for exercise of options (in shares)	0
Common stock issued (in shares)		444,444
Common stock issued	$ 1,540,943	$ 444	1,540,499
Common stock issued for Employee Stock Purchase Plan (in shares)		8,405
Common stock issued for Employee Stock Purchase Plan	85,491	$ 9	85,482
Common stock issued for acquisition (in shares)		64,746
Common stock issued for acquisition	406,158	$ 65	406,093
Rescission of warrant exercise	0
Warrant exercises (in shares)		444,445
Warrant exercises	11,643,865	$ 444	11,643,421
Common stock received in sale of business (in shares)		(5,060)
Common stock received in sale of business	(30,250)	$ (5)	(30,245)
Vesting of Restricted Stock Units (in shares)		1,298
Vesting of Restricted Stock Units	0	$ 1	(1)
Reverse stock split adjustment (in shares)		3,116
Reverse stock split adjustment	0	$ 3	(3)
Stock-based compensation (in shares)		27,035
Stock-based compensation	198,898	$ 27	198,871
Contributions	6,892,395		4,722,970		2,169,425
Distributions	(6,437,966)				(6,437,966)
Net income (loss)	94,805,484			52,096,040	42,709,444
End balance (in shares) at Dec. 31, 2024		5,511,452
Ending balance at Dec. 31, 2024	$ 188,531,812	$ 5,511	$ 489,408,981	$ (356,976,499)	$ 56,093,819